Oliver Bogler studied natural sciences at Cambridge University, graduated at 1988, and then moved to the Laboratory of Dr. Mark Noble, Ludwig Institute for Cancer Research, University College Branch in London, UK, for his Ph.D. work, which he completed in 1991. Following a postdoctoral work at the Salk Institute in Developmental Neurobiology, he rejoined the Ludwig Institute, working with Dr. Webster Cavenee, the Director of the San Diego Branch. His first faculty appointment (1997) was in the Departments of Anatomy and Neurosurgery at Virginia Commonwealth University in Richmond. In 2000, he moved to the Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, USA, and was promoted to be an Associate Professor in 2002. In 2005, Dr. Bogler joined the Department of Neurosurgery and the Brain Tumor Center at the UT MD Anderson Cancer Center as the Director of Basic Research, and he was promoted to be a Professor in 2009. His research is focused on EGFR signaling in glioma and novel platinum compounds. In July 2010, Dr. Bogler accepted the position of Vice President for Global Academic Programs in MD Anderson's Center for Global Oncology, where he oversees academic relationships external to MD Anderson's main campus in Houston. In September 2011, he was appointed Senior Vice President for Academic Affairs and oversees 16 departments that deliver support for the academic and education activities at MD Anderson.
Biography Updated on 3 December 2011